Does caffeine shampoo help hair loss?

Limited clinical trial evidence suggests topical caffeine may modestly reduce hair loss. One small RCT found it comparable to minoxidil 5% over 6 months, but without a placebo comparison. The evidence quality is low and it is not FDA-approved for hair loss.

How does caffeine affect hair growth?

Caffeine inhibits phosphodiesterase, increasing cyclic AMP in hair follicle cells. In vitro studies show this stimulates follicle growth and may counteract DHT suppression. Whether this translates to clinically significant results in humans at shampoo concentrations is not established.

Is Alpecin caffeine shampoo effective?

Alpecin is the most widely marketed caffeine shampoo. The clinical evidence for caffeine shampoo in general is limited, and no large placebo-controlled trial has tested Alpecin specifically. The general caffeine evidence is discussed above.

Is caffeine shampoo as good as minoxidil?

The Dhurat 2017 trial found caffeine 0.2% solution non-inferior to minoxidil 5% over 6 months in one outcome measure. However, this single small trial without a placebo group does not establish equivalence. Minoxidil has a far larger, more rigorous evidence base and FDA approval.

Does caffeine shampoo have any side effects?

Topical caffeine is generally well tolerated. Some scalp irritation is possible. Systemic absorption from shampoo is minimal. No serious adverse effects have been reported in clinical trials.

Should I use caffeine shampoo or a caffeine serum for hair loss?

Leave-in caffeine serums or solutions would theoretically provide longer scalp contact time than shampoos, which are rinsed off quickly. The Dhurat 2017 trial used a solution, not a shampoo. Whether shampoo formulations deliver adequate concentrations to the follicle is not confirmed.

Caffeine Shampoo for Hair Loss: Evidence Review

Last updated: Apr 20, 2026Fact CheckTopical CaffeineBased on 3 studies

This is a research-based fact check, not medical advice. The findings summarized here come from peer-reviewed studies and are presented without added opinions. Consult a certified healthcare practitioner before making any treatment decision.

Verdict

Topical caffeine has limited clinical trial evidence for hair loss. One small RCT (Dhurat 2017) found caffeine 0.2% solution produced results comparable to minoxidil 5% over 6 months in men with pattern hair loss. Two 2025 systematic reviews found limited but positive evidence for topical caffeine. The evidence base is substantially weaker than for approved treatments. Caffeine is not FDA-approved for hair loss. Shampoo formulations have very short scalp contact time, raising questions about effective delivery.

Key takeaways

Topical caffeine is not FDA-approved for hair loss.
One small RCT (Dhurat 2017) found caffeine 0.2% solution comparable to minoxidil 5% over 6 months.
Two 2025 systematic reviews found limited but positive evidence across small studies.
In vitro studies confirm caffeine stimulates hair follicle growth via phosphodiesterase inhibition.
Shampoo formulations have very short scalp contact time, which may limit active delivery to follicles.
Evidence quality is substantially below that of minoxidil or finasteride.

Topical caffeine is not FDA-approved for hair loss. Evidence from clinical trials is limited to small studies.

Clinical evidence

The Dhurat 2017 RCT compared caffeine 0.2% topical solution against minoxidil 5% solution in 210 men with androgenetic alopecia over 6 months. The primary outcome (hair loss reduction) was comparable between groups, with no statistically significant difference. This was interpreted as non-inferiority. However, neither group was compared against placebo in this trial, which limits interpretation of the absolute effect size. Context on approved hair loss treatments is in the hair restoration guide.

Two 2025 systematic reviews (Ly 2025, Szendzielorz 2025) synthesised the available evidence on topical caffeine for hair loss. Both found that while results across small studies are directionally positive, the overall evidence quality is low, sample sizes are small, follow-up periods are short, and heterogeneity between studies is high.

Mechanism

Caffeine is a phosphodiesterase inhibitor. Phosphodiesterase breaks down cyclic AMP (cAMP), a second messenger involved in cell proliferation and hair follicle cycling. By inhibiting phosphodiesterase, caffeine increases cAMP levels in hair follicle cells, which has been shown in vitro to stimulate hair shaft elongation and extend the anagen (growth) phase. DHT suppresses these pathways; caffeine may partially counteract this. The in vitro evidence is robust, but translating in vitro findings to clinically meaningful results in humans is not straightforward.

Shampoo vs leave-in formulations

Most widely sold caffeine products are shampoos (e.g. Alpecin). Shampoos are applied, lathered, and rinsed within minutes. The scalp contact time for caffeine delivery is much shorter than a leave-in solution. In vitro penetration studies suggest caffeine can penetrate the hair follicle from shampoo within 2 minutes of scalp contact, but whether this translates to biologically relevant concentrations at the follicle bulb is not confirmed in controlled human studies. Leave-in caffeine formulations (serums, solutions) would theoretically deliver more sustained exposure.

Study	Patients	Key finding
Dhurat 2017: caffeine 0.2% vs minoxidil 5% RCT	RCT (n=210)	Caffeine 0.2% solution non-inferior to minoxidil 5% over 6 months on hair loss reduction. No placebo control.
2025 systematic review: caffeine cosmetics for hair loss	Systematic review	Limited but positive evidence across small studies. Evidence quality low.
Ly 2025: topical caffeine for hair loss	Systematic review	Positive direction across studies; methodological limitations prevent strong conclusions.

What the research cannot tell you

Whether caffeine shampoo (as distinct from caffeine solution) delivers sufficient active ingredient to produce meaningful hair growth.
The effective minimum concentration of topical caffeine for hair loss benefit.
Long-term outcomes beyond 6 months in any controlled caffeine trial.
Whether caffeine is additive to minoxidil or finasteride when used together.